A new genomics partnership fusing AI, liquid biopsy and a huge repository of genomic data aims to improve the prescription of immunotherapies for cancer patients in the U.K. Photo credit: Getty royalty-free
A new genomics partnership fusing AI, liquid biopsy and a huge repository of genomic data aims to improve the prescription of immunotherapies for cancer patients in the U.K. Photo credit: Getty royalty-free